Product image of Norifaz Trio (Colecalciferol, Calcium Carbonate | Risedronate Sodium) supplied by GNH India

Norifaz Trio

Active Ingredient:
Colecalciferol, Calcium Carbonate | Risedronate Sodium
Origin:
EU

Norifaz Trio (Colecalciferol, Calcium Carbonate | Risedronate Sodium)

Colecalciferol/Calcium carbonate/Risedronate sodium, the active ingredient in Norifaz Trio, is a bisphosphonate, calcium supplement and vitamin D supplement presented as an oral tablet for oral use. It is used to treat osteoporosis and to reduce fracture risk in adults at risk of bone loss.

GNH India supplies Norifaz Trio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Zentiva, K.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norifaz Trio, a combination bisphosphonate, calcium and vitamin D product, is indicated for conditions involving bone loss.

  • Osteoporosis: reduces the risk of vertebral and non‑vertebral fractures.
  • Prevention of bone loss: helps maintain bone mineral density in post‑menopausal women.
  • Fracture risk reduction: lowers the incidence of fragility fractures in patients with low bone mass.

How It Works

  • Risedronate sodium binds to bone hydroxyapatite and is internalized by osteoclasts, where it inhibits farnesyl pyrophosphate synthase, suppressing osteoclast‑mediated bone resorption. Calcium carbonate supplies elemental calcium for mineral deposition, while colecalciferol (vitamin D3) enhances intestinal calcium absorption and supports normal bone remodeling.

Side Effects

Common side effects are generally mild and affect the gastrointestinal tract.

Common Side Effects

  • Nausea: mild stomach upset.
  • Abdominal pain: discomfort in the abdomen.
  • Constipation: difficulty passing stools.
  • Dyspepsia: indigestion or heartburn.

Serious or Rare Side Effects

  • Osteonecrosis of the jaw: exposed bone in the jaw area.
  • Atypical femur fracture: unusual break in the thigh bone.
  • Severe hypersensitivity: rash, swelling, or anaphylaxis.
  • Acute renal impairment: sudden decrease in kidney function.

Precautions & Warnings

Before initiating therapy, clinicians should assess several safety factors.

  • Renal function: evaluate kidney status and adjust use if impaired.
  • Gastrointestinal disorders: monitor for esophageal irritation or ulceration.
  • Calcium intake: ensure adequate dietary calcium to support supplementation.
  • Vitamin D status: correct deficiency before starting treatment.
  • Concomitant medications: avoid taking oral calcium or iron supplements within two hours of the dose.
  • Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Avoid Interactions

Norifaz Trio may interact with other medicines that affect bone or mineral metabolism.

Major Interactions (Avoid)

  • Other bisphosphonates: concurrent use can increase toxicity.
  • Simultaneous oral calcium, iron, or antacids within 2 hours: markedly reduces risedronate absorption.
  • NSAIDs: increase risk of gastrointestinal irritation.
  • Severe renal impairment: contraindicated due to reduced clearance.

Moderate Interactions (Monitor Closely)

  • Proton pump inhibitors: may modestly affect absorption.
  • Glucocorticoids: can diminish bone‑protective effect.
  • Loop or thiazide diuretics: may alter calcium balance.

Frequently Asked Questions

Norifaz Trio is a prescription oral medication that combines risedronate sodium, calcium carbonate and colecalciferol (vitamin D3) to treat osteoporosis, help prevent bone loss, and lower the risk of fragility fractures in adults with reduced bone mineral density.

Risedronate sodium inhibits osteoclast‑mediated bone resorption, calcium carbonate supplies elemental calcium for bone mineralization, and colecalciferol enhances intestinal calcium absorption, together supporting stronger bone structure and reducing fracture risk.

The specific dose and dosing schedule of Norifaz Trio are determined by the prescribing clinician based on the patient’s medical condition, renal function, and other individual factors. Patients should follow the prescriber’s instructions exactly.

Safety of Norifaz Trio in pregnancy or while breastfeeding has not been fully established. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies for pregnant or nursing individuals.

To request Norifaz Trio, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Norifaz Trio combines a bisphosphonate with calcium and vitamin D, offering both anti‑resorptive action and essential mineral supplementation in a single tablet. Compared with single‑ingredient bisphosphonates, it may simplify therapy by reducing the need for separate calcium or vitamin D supplements.

Norifaz Trio should be stored at ambient temperature, preferably below 25 °C, in its original blister pack to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Norifaz Trio is taken orally, usually on an empty stomach with a full glass of water at least 30 minutes before the first food, beverage, or other medication of the day. Patients should remain upright for at least 30 minutes after ingestion to reduce esophageal irritation.

Serious risks include osteonecrosis of the jaw, atypical femur fractures, severe hypersensitivity reactions, and acute renal impairment. Patients should report persistent jaw pain, unusual thigh pain, signs of allergic reaction, or sudden changes in urine output to their healthcare provider promptly.

Norifaz Trio is contraindicated in individuals with severe renal impairment, known hypersensitivity to any component, esophageal abnormalities that delay emptying, or those who are unable to sit or stand upright for at least 30 minutes after dosing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Colecalciferol, Calcium Carbonate | Risedronate Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT